Blueprint Medicines Corporation(NASDAQ:BPMC) 
Blueprint Medicines Corporation, a precision therapy company, develops medicines for people with cancer and hematologic disorders, and multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy in the United States and Europe. The company is developing avaprit...
Website: http://www.blueprintmedicines.com
Founded: 2008
Full Time Employees: 420
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-11-29
P
O 95.70
H 97.98
L 95.05
C 96.38
V 338,235
10EMA 96.38
20EMA 96.38
60EMA 96.38
120EMA 96.38
250EMA 96.38